Surgical treatment of a periapical lesion in a patient with a history of alendronate-associated osteonecrosis
DOI:
https://doi.org/10.33448/rsd-v15i4.50972Keywords:
Osteonecrosis of the jaws, Bisphosphonates, Alendronate, Parendodontic surgery.Abstract
Medication-related osteonecrosis of the jaws is a clinical complication associated with the use of antiresorptive agents, especially alendronate, which may impair bone remodeling and tissue repair, increasing the risk of complications after procedures. The aim of this study is to report a clinical case of surgical treatment of a periapical lesion in a patient with a history of medication-related osteonecrosis of the jaws associated with alendronate use, highlighting the therapeutic approach adopted and the clinical outcomes obtained. A 62-year-old female patient, with a history of alendronate use for more than 10 years, discontinued two years earlier after a previous episode of osteonecrosis, presented with a persistent periapical lesion associated with teeth 31 and 32. Clinical and tomographic evaluation confirmed the diagnosis, and laboratory tests were within normal limits. Surgical treatment consisted of lesion curettage, apicectomy without retrograde filling, use of platelet-rich fibrin, and low-level laser therapy, associated with preoperative antibiotic therapy. Postoperative follow-up at 10 and 30 days showed adequate tissue healing and favorable progression of bone repair, with no signs of infection, recurrence, or osteonecrosis. Parendodontic surgery may be a viable and safe alternative in patients with a history of prolonged bisphosphonate use and previous osteonecrosis, provided that careful case selection is performed, minimally invasive techniques are adopted, and adjuvant therapies are used to promote healing and reduce the risk of complications.
References
Ahmed, A., Jain, P. V., & Devi, M. S. (2026). Timing of dental surgery in patients receiving bone-modifying agents: Medication-related osteonecrosis of the jaw (MRONJ) and implant outcomes in a cohort of 5,284 oncology patients within an integrated dental pathway. Journal of Clinical and Experimental Dentistry, 18(2), e175–e182.
Dohan Ehrenfest, D. M., Rasmusson, L., & Albrektsson, T. (2009). Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends in Biotechnology, 27(3), 158–167.
Gosavi, S., Marwaha, J., Binmuhana, N. O., et al. (2025). Comparison of AI-based radiographic interpretation versus endodontic specialists for identifying periapical lesions. Bioinformation, 21(12), 4831–4836.
Khan, A. A., Morrison, A., Hanley, D. A., et al. (2015). Diagnosis and management of osteonecrosis of the jaw. Journal of Bone and Mineral Research, 30(1), 3–23.
Khosla, S., Burr, D., Cauley, J., et al. (2007). Bisphosphonate-associated osteonecrosis of the jaw. Journal of Bone and Mineral Research, 22(10), 1479–1491.
Miron, R. J., Fujioka-Kobayashi, M., Bishara, M., et al. (2017). Platelet-rich fibrin and soft tissue wound healing. Tissue Engineering Part B: Reviews, 23(1), 83–99.
Mora, M., Craig, J. R., Mehta, S., et al. (2026). Prevalence and predisposing factors of periapical mucositis. International Endodontic Journal.
Otto, S., Pautke, C., Opelz, C., et al. (2011). Osteoporosis and bisphosphonates-related osteonecrosis of the jaw. Journal of Cranio-Maxillofacial Surgery, 39(4), 272–277.
Pereira, A. S. et al. (2018). Metodologia da pesquisa científica. [Free ebook]. Santa Maria. Editora da UFSM.
Risemberg, R. I. C., Wakin, M., & Shitsuka, R. (2026). A importância da metodologia científica no desenvolvimento de artigos científicos. E-Acadêmica, 7(1), e0171675. https://doi.org/10.52076/eacad-v7i1.675.
Ruocco-Vetucci, V., Chaves, R. A. C., Ballan, A. C. F., et al. (2026). Preclinical assessment of leukocyte- and platelet-rich fibrin. General Dentistry, 74(2), 22–29.
Ruggiero, S. L., Dodson, T. B., Aghaloo, T., et al. (2022). AAOMS position paper on medication-related osteonecrosis of the jaw—2022 update. Journal of Oral and Maxillofacial Surgery, 80(5), 920–943.
Småland-Reksten, A., Agger, A. E., Lian, A. M., et al. (2026). Bisphosphonate and statin effects on wound healing. Acta Odontologica Scandinavica, 85, 125–133.
Toassi, R. F. C. & Petry, P. C. (2021). Metodologia científica aplicada à área da saúde. (2ed). Editora da UFRGS.
Uehara, K., Kato, K., Tsuji, S., et al. (2026). Necrotic-cell-activated macrophages and bisphosphonate resistance. Biochemical and Biophysical Research Communications.
Yang, G. (2026). Differential healing patterns of odontogenic maxillary sinusitis following nonsurgical endodontic therapy: A cone-beam computed tomography-based case series. Journal of Endodontics. Advance online publication. https://doi.org/10.1016/j.joen.2026.03.013
Yarom, N., Shapiro, C. L., Peterson, D. E., et al. (2019). Medication-related osteonecrosis of the jaw: MASCC/ISOO/ASCO clinical practice guideline. Journal of Clinical Oncology, 37(25), 2270–2290.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Augustho Molina Frederico
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
